HBV-IN-53
HBV-IN-53 (Compound 1) is an HBV inhibitor. HBV-IN-53 reduces the level of HBV DNA in serum. The inhibitory activity of HBV-IN-53 in combination with Tenofovir disoproxil fumarate (HY-13782) exhibits an additive effect on HBV inhibition[1].
Product Specifications
CAS Number
[2243162-67-4]
UNSPSC
12352005
Target
DNA/RNA Synthesis; HBV
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Field of Research
Infection
Smiles
O=S1(N2C(C(NC3=CC(C(NCC[C@@H]4COCCO4)=O)=CC=C31)=O)=CC(C)=C2)=O
Molecular Formula
C19H21N3O6S
Molecular Weight
419.45
References & Citations
[1]Wu, et al. Combination comprising tricycle compound and use thereof in preparation of medicament for treating hbv. WO2021228213A1. WIPO (PCT) . 2021-05-14.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
